Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroimaging Omega-3 and Reward in Adults With ADHD (NORAA) Trial

NCT02156089 is registered in ClinicalTrials.gov with National Institute on Alcohol Abuse and Alcoholism (NIAAA) as lead sponsor.

NCT NCT02156089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02156089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroimaging Omega-3 and Reward in Adults With ADHD (NORAA) Trial
Lead sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Phase
Phase 2
Overall status
Terminated
Start date
June 4, 2014
Completion date
December 21, 2018
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit disorder, attention deficit hyerpactivity disorder